Roivant will begin trading on Nasdaq under the ticker “ROIV” later today R&D Day presentations from September 28th highlighting Roivant’s pipeline and discovery platform available on Roivant’s investor page BASEL, Switzerland and LONDON and NE...
Jeff Smith’s 13F portfolio value increased from ~$3.93B to ~$4.69B this quarter. Starboard Value added Elanco Animal Health and eHealth, while dropping Advanced Auto Parts this quarter. The largest three individual stock positions are Corteva, Aecom, and NortonLifeLock. The...
Palantir has invested in 6 SPACs over the past year. Each of these innovative investment companies is seeking to use data to disrupt massive industries. I dive into each of these investments, the opportunity they represent, and why Palantir invested in them. For further deta...
Roivant Provides Corporate Updates - Datavant and Ciox Health have signed a definitive merger agreement - Combined company positioned to solve the challenge of health data fragmentation - Additional Roivant milestones this past month include 5th NDA submission and 3rd FD...
SPACs, biotechnology and deals where insiders buy out minority investors are all at the more complex end of company finance. Roivant Sciences has found a way to combine all three. Roivant has about 58% of Immunovant, which at $1.5 billion is worth two-thirds less than it was at the en...
Sam Zell's Equity Commonwealth (EQC) wins bidding war for Monmouth Real Estate Investment Corporation (MNR) but arbitrageurs are expecting more. Farm Bureau Property & Casualty Insurance Company bumps up its offer price for FBL Financial Group (FFG) to $61 per share from its previ...
SPAC Montes Archimedes Acquisition (MAAC) shares up 2.5% premarket on taking Roivant Sciences, a biopharmaceutical and healthcare technology company public at $7.3B valuation.Upon closing of the transaction, outstanding shares and warrants of MAAC will be exchanged for newly issued ...
Roivant Sciences and Montes Archimedes Acquisition Corp. (MAAC) to Combine and Create Publicly Traded Leader in Biopharma and Health Technology - Transaction includes $411 million in trust at MAAC and a concurrent, fully committed $200 million PIPE financing from leading healthc...
News, Short Squeeze, Breakout and More Instantly...
Montes Archimedes Acquisition Corp. Company Name:
MAAC Stock Symbol:
NASDAQ Market:
Roivant will begin trading on Nasdaq under the ticker “ROIV” later today R&D Day presentations from September 28th highlighting Roivant’s pipeline and discovery platform available on Roivant’s investor page BASEL, Switzerland and LONDON and NE...
Roivant Provides Corporate Updates - Datavant and Ciox Health have signed a definitive merger agreement - Combined company positioned to solve the challenge of health data fragmentation - Additional Roivant milestones this past month include 5th NDA submission and 3rd FD...
Roivant Sciences and Montes Archimedes Acquisition Corp. (MAAC) to Combine and Create Publicly Traded Leader in Biopharma and Health Technology - Transaction includes $411 million in trust at MAAC and a concurrent, fully committed $200 million PIPE financing from leading healthc...